FACULTAD DE MEDICINA
Facultad
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (30)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
Clinical Microbiology and Infection, Vol. 29, Núm. 1, pp. 85-93
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
2022
-
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181
-
Cadmium exposure and growth differentiation factor-15 (GDF-15) levels in non-smoking older adults
Environmental Research, Vol. 206
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain
International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1
-
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies
International Journal of Molecular Sciences, Vol. 23, Núm. 11
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Characterization of methicillin-resistant Staphylococcus aureus strains colonizing the nostrils of Spanish children
MicrobiologyOpen, Vol. 10, Núm. 5
-
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 7, pp. e2026-e2033
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Selenium and impaired physical function in US and Spanish older adults
Redox Biology, Vol. 38
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
-
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Journal of acquired immune deficiency syndromes (1999), Vol. 83, Núm. 3, pp. 292-300
-
Staphylococcus aureus nasal colonization in Spanish children. The COSACO nationwide surveillance study
Infection and Drug Resistance, Vol. 13, pp. 4643-4651